Globe Newswire
ALLIANCE TRUST PLC At the close of business Tuesday 07 May 2024:
The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was
- excluding income, 1271.5p - including income, 1278.1p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was
- excluding income, 1275.7p
- including... (continue reading...)
HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close.
STRATA management will host a conference call at 4:30 p.m. ET on... (continue reading...)
WASHINGTON, May 08, 2024 (GLOBE NEWSWIRE) -- The Council of Federal Home Loan Banks, the public voice of the Federal Home Loan Bank System (FHLBank System), today issued the following statement attributable to Council President and CEO, Ryan Donovan, in reaction to FHLBank San Francisco’s announcement of Alanna McCargo as its new President and Chief Executive Officer.
“We congratulate Alanna McCargo on her selection as President of the Federal Home Loan Bank of... (continue reading...)
OMAHA, Neb., May 08, 2024 (GLOBE NEWSWIRE) -- On May 8, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2024.
Financial Highlights
The Partnership reported the following results as of and for the three months ended March 31, 2024:
- Net income of $0.42 per Beneficial Unit Certificate (“BUC”), basic and diluted
- Cash Available for Distribution (“CAD”) of $0.23 per... (continue reading...)
Blink Care is an optional maintenance program designed to reduce charger downtime and provide a more seamless charging experience.
Bowie, Md., May 08, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced the launch of Blink Care, a new, optional preventative maintenance program aimed at... (continue reading...)
More Globe Newswire
View Older Stories-
Update on Debt Funding
-
Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine
-
Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine
-
Foresight Leverages NVIDIA Jetson Orin to Introduce Novel 360-degree 3D Perception Solution
-
Beztak Recognized as a US Best Managed Company
-
Applied Digital Announces Upcoming Conference Participation
-
Payment of dividend
-
Alanna McCargo Named President and Chief Executive Officer of the Federal Home Loan Bank of San Francisco
-
Captura Advances to the Top 20 Finalists in XPRIZE Carbon Removal Competition
-
Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
-
First Merchants Corporation Announces Cash Dividend
-
Terra Balcanica Announces Proposed Share Consolidation and Engages Market Maker
-
United Way of Metropolitan Dallas Chooses SylogistMission
-
Optiva Awarded ISO 27001 Certification Demonstrating Commitment to Cybersecurity
-
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
-
Puma Launches 2024 Exploration Program at Jonpol Gold
-
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
-
Core Molding Technologies to Participate in the EF Hutton Annual Global Conference in NYC
-
TytoCare and Urgent Care Association to Host Major Health System Leaders for Rural & Urgent Care Clinic Virtual Summit
-
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
-
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
-
LGI Homes Announces its Second Community in the Modesto Market
-
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
-
Jewelry Franchisee The Michaels Group Chooses Clip for Secure, Cost-Effective Cash Management
-
StarTree Extends Real-Time Analytics Capabilities for Observability and Anomaly Detection Use Cases
-
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024
-
MEDIA ADVISORY: INTERVIEW OPPORTUNITIES
-
Fobi AI Partners with Verifiction to Enhance Data Verification and Cyber Security Protection
-
Horizon Aircraft Provides Update on Technical Flight Testing Progress
-
TSS, INC. TO REPORT FIRST QUARTER 2024 RESULTS ON TUESDAY, MAY 15th, 2024
-
SRAX Signs Agreement to Merge with DNA Holdings
-
HF Foods Reports First Quarter 2024 Financial Results
-
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
-
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
-
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock
-
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects
-
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
-
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
-
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
-
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
-
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
-
Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
-
ArriVent BioPharma Reports First Quarter 2024 Financial Results
-
TytoCare and Urgent Care Association to Host Major Health System Leaders for Rural & Urgent Care Clinic Virtual Summit
-
Gen Z Consumers Are Using Credit More, and Differently, than Their Millennial Counterparts at the Beginning of their Credit Journeys
-
BioAtla to Participate in the Citizens JMP Life Sciences Conference